CapsoVision, Inc. (CV)
10.69
-1.70
(-13.72%)
USD |
NASDAQ |
Dec 31, 16:00
10.90
+0.21
(+1.96%)
After-Hours: 20:00
CapsoVision EPS Diluted (Quarterly): -0.1693 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Catheter Precision, Inc. | -1.705 |
| Picard Medical, Inc. | -0.1915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.921M |
| Revenue (Quarterly) | 3.538M |
| Total Expenses (Quarterly) | 11.46M |
| Enterprise Value | 483.94M |
| Gross Profit Margin (Quarterly) | 54.10% |
| Profit Margin (Quarterly) | -223.9% |
| Earnings Yield | -4.76% |
| Normalized Earnings Yield | -4.732 |